Search Results 391-400 of 17246 for SC

  1. Twins take action: diagnosed with Tay-Sachs, sisters raise awareness to find treatment and a cure

    As a result, she has relocated from New York to Hilton Head, South Carolina, where she works remotely as an assistant planner for a large retailer. Allie ...

  2. Alumni - Dermatology Residency (Minnesota) - Mayo Clinic College of Medicine and Science

    After completing residency in 2017, I joined Dermatology Associates of Greenville, SC. I currently work alongside six other excellent dermatologists. My ...

  3. Publications - Niti R. Aggarwal, M.D. - Mayo Clinic

    ... SC, Sweitzer B, Talbot AW, Vallabhajosyula S, Whittle J, Williams KA Sr, Writing Committee Members. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline ...

  4. Eddie L. Greene, M.D. - Doctors and Medical Staff - Mayo Clinic

    ... South Carolina. 1999 - 2000. FellowSouthern Society for Clinical ... MemberDiabetes Initiative of South Carolina, Medical University of South Carolina.

  5. Publications - Wolfgang Singer, M.D. - Mayo Clinic

    Is EE, Ciftci Inceoglu S, Tekin SC, Albayrak B, Sonsoz MR, Kuran B, Singer W. Validation and reliability of the Turkish version of the composite autonomic ...

  6. Publications - Cheryl L. Willman, M.D. - Mayo Clinic

    ... SC, Gastier-Foster JM, Harvey R, Chen IM, Roberts KG, Mullighan CG, Willman C, Winick N, Carroll WL, Rau RE, Teachey DT, Hunger SP, Raetz EA, Devidas M ...

  7. New progress in development of gene therapy for arthritis - Mayo Clinic

    Evans CH, et al. The vicissitudes of gene therapy. Bone & Joint Research. 2019;10:469. Mayo Clinic. Safety of Intra-Articular Sc-rAAV2.

  8. Publications - Mayra Guerrero, M.D. - Mayo Clinic

    Malaisrie SC, Zajarias A, Leon MB, Mack MJ, Pibarot P, Hahn RT, Brown D, Wong SC, Oldemeyer JB, Shang K, Leipsic J, Blanke P, Guerrero M. Transcatheter ...

  9. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    MTX: ≥ 15 mg/week subcutaneous (SC) or intramuscular (IM); ... At least one 4-week induction regimen of golimumab (200 mg SC at Week 0 and 100 mg SC at Week 2); ...

  10. Selected Publications by Faculty and Fellows Source: Cho, J. Seville, MT. Khanna, S. Pardi, DS. Sampathkumar, P. Kashyap, PC. Sc

    Source: Cho, J. Seville, MT. Khanna, S. Pardi, DS. Sampathkumar, P. Kashyap, PC. Screening for. Clostridium difficile colonization on admission to a ...